Similar articles

• Gene therapy and pancreatic cancer.

  Clary BM, Lyerly HK. Clary BM, et al. Surg Oncol Clin N Am. 1998 Jan;7(1):217-49. Surg Oncol Clin N Am. 1998. PMID: 9443997 Review.
• Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.

  Zhang YA, Nemunaitis J, Samuel SK, Chen P, Shen Y, Tong AW. Zhang YA, et al. Cancer Res. 2006 Oct 1;66(19):9736-43. doi: 10.1158/0008-5472.CAN-06-1617. Cancer Res. 2006. PMID: 17018633
• [Molecular mechanism in pancreatic carcinogenesis: Ras gene].

  Ohnami S, Aoki K, Yoshida T. Ohnami S, et al. Nihon Rinsho. 2006 Jan;64 Suppl 1:32-5. Nihon Rinsho. 2006. PMID: 16457216 Review. Japanese. No abstract available.
• Gene therapy for pancreatic cancer.

  Kasuya H, Nomoto S, Kimata H, Harada A, Takeda S, Hayashi S, Nakao A. Kasuya H, et al. Hepatogastroenterology. 2001 Jul-Aug;48(40):957-61. Hepatogastroenterology. 2001. PMID: 11490848 Review.
• [Antisense N-ras1 gene inhibits the proliferation of VSMC induced by bFGF after arterial injury].

  Zhou Y, Wang L, Zhou A. Zhou Y, et al. Zhonghua Yi Xue Za Zhi. 1998 Mar;78(3):227-9. Zhonghua Yi Xue Za Zhi. 1998. PMID: 10923539 Chinese.